A comprehensive 15-year study of paracetamol poisoning admissions in New South Wales, Australia, has revealed that while severe liver injury remains uncommon, patients face substantial risks of repeated poisoning attempts and long-term mortality. The findings challenge assumptions about paracetamol overdose outcomes and highlight critical gaps in post-overdose mental health care.
Paracetamol poisoning outcomes and long-term risks
Patient outcomes following hospital admission for paracetamol poisoning, NSW 2009-2023
poisonings
within 5 years
liver injury
Source: PAVLOVA-3 study, The Lancet Regional Health 2026 | Georgian Medical Journal News
Intentional Overdoses Dominate Hospital Admissions
The PAVLOVA-3 study, published in The Lancet Regional Health – Western Pacific, analyzed 12,047 paracetamol poisoning admissions across New South Wales from 2009 to 2023. The study found that 85.2% of cases were intentional overdoses, predominantly among young adults seeking self-harm.
According to the PAVLOVA-3 study, women accounted for 68.3% of intentional poisonings, with the highest rates occurring among individuals aged 15-24 years. Severe hepatotoxicity requiring liver transplantation or resulting in death occurred in only 4.7% of cases, according to the study findings.
Repeat Poisoning Attempts Create Ongoing Risk
The most striking finding was the high rate of repeated paracetamol poisoning attempts. Within five years of their initial admission, 23.1% of patients returned to hospital for another paracetamol overdose, according to the linked data analysis published in the PAVLOVA-3 study.
The World Health Organization estimates that individuals who attempt self-harm are 100 times more likely to die by suicide within a year compared to the general population.
The PAVLOVA-3 study tracked patients through multiple healthcare databases, including emergency department visits, hospital admissions, and death records. This comprehensive approach revealed patterns invisible in single-episode studies and highlighted the need for integrated health system responses that extend beyond acute care.
Long-term Mortality Rates Exceed Expected Levels
The PAVLOVA-3 study found that mortality rates remained significantly higher than age-matched population controls for up to 15 years following the initial overdose. This excess mortality was attributed to both suicide and other causes in the study findings.
The research team used sophisticated statistical modeling to account for socioeconomic factors, comorbidities, and healthcare access patterns, according to the published study. Even after these adjustments, patients who survived paracetamol poisoning showed persistently elevated risks of premature death according to the PAVLOVA-3 findings.
Healthcare System Implications and Policy Responses
The study’s findings have prompted calls for revised clinical protocols and health system reforms in Australia. The Australian Department of Health has indicated plans to review current guidelines for paracetamol poisoning management in light of these results.
The PAVLOVA-3 study recommends implementing standardized mental health screening for all paracetamol poisoning admissions, regardless of stated intent. The researchers also advocate for mandatory follow-up appointments with mental health services and improved coordination between emergency departments, toxicology services, and community mental health teams.
While severe liver injury occurred in only 4.7% of paracetamol poisoning cases, 23.1% of patients experienced repeat poisoning within five years, with persistently elevated mortality risks lasting up to 15 years.
— PAVLOVA-3 study findings (The Lancet Regional Health – Western Pacific, 2026)
Key takeaways
- Paracetamol poisoning admissions are predominantly intentional (85.2%) and occur most frequently among women aged 15-24 years, according to the PAVLOVA-3 study
- Nearly one in four patients (23.1%) experiences repeat paracetamol poisoning within five years of initial admission, per study findings
- Long-term mortality rates remain elevated for up to 15 years following paracetamol overdose, according to the PAVLOVA-3 research
- The study findings suggest current hospital protocols focus on acute toxicity management but inadequately address underlying mental health needs
Frequently asked questions
How common is severe liver damage from paracetamol poisoning?
According to the PAVLOVA-3 study, severe hepatotoxicity requiring liver transplantation or resulting in death occurred in only 4.7% of paracetamol poisoning cases. Most patients recover from the acute toxicity without lasting liver damage.
Why do so many people repeat paracetamol overdoses?
The PAVLOVA-3 study found that 23.1% of patients had repeat poisoning within five years, reflecting underlying mental health conditions that often go unaddressed after the initial episode.
What changes are recommended for treating paracetamol overdose patients?
The PAVLOVA-3 study recommends implementing routine mental health screening for all cases, mandatory follow-up with mental health services, and better coordination between emergency departments and community mental health teams to address long-term risks.
The PAVLOVA-3 study represents one of the largest and most comprehensive analyses of paracetamol poisoning outcomes to date. Its findings are likely to influence clinical guidelines and health policy decisions across multiple countries, as healthcare systems grapple with the dual challenges of acute poisoning management and long-term mental health support.
